Browse treatments

…peutic strategy to overcome resistance to immunotherapy such as CAR T cell therapy in HCC.…

… trial registries will be searched for clinical trials on MASLD pharmacotherapy. Histological, radiological and paraclinical outcomes will be c…

…io)), quality of life advantages of talazoparib (Talzenna) over chemotherapy, and functional benefits of trastuzumab deruxtecan (Enhertu).A …

…s and patients with low socioeconomic status had lower rates of multiarterial grafting. QI efforts should be evaluated both overall and among patients…

…ond the 4.5-hour therapeutic window, it remains unknown whether intravenous thrombolysis before EVT is beneficial. This study hypothesised that treatmen…

…), autoimmune disease (OR 4.69; 95% CI 1.15 to 19.09; p=0.031), chemotherapy or radiotherapy (OR 4.25; 95% CI 1.09 to 16.58; p=0.037), hormone therapy (OR 2…

…ophysin expression. Despite timely whole-brain radiotherapy and chemotherapy, his condition deteriorated rapidly, and he succumbed within we…

…n level and resolution of volume overload. She was treated with immunosuppression for a primary MN with good clinical response. This case highlig…

… 90–93% are at increased risk of mortality and may benefit from oxygen therapy. We aimed to determine the feasibility of a randomised controll…

…uspected ANOCA/INOCA, outcomes were dominated by chest pain and IMT did not improve outcomes, although limited power precludes conc…

…y limits the active and passive mobility of the shoulder joint. Physical therapy (PT) combined with intra-articular steroid (IAS) injection and …

…e after intra-abdominal surgery is to temporarily transition to haemodialysis in patients who require dialysis, we demonstrate that immediate…